In the News
powered by Ovast-
CrystalGenomics Scores KRW 3 Billion In Strategic Equity Investment From KSLSF, A Life Science Fund Backed By The City Of Seoul
pr.com 4 weeks, 1 day agoCrystalGenomics, Inc. (KOSDAQ: CRYSTAL [083790]), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF). This is the third time within the past month that CrystalGenomics has raised capital following a KRW 10 Billion bond issuance to KDB Capital, a major [PR.com]










Loading More Stories